Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL7748929 | 0.97 | SLC34A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL7748933 | 0.97 | SLC34A1 (0.50) | — | |
| Phosphoric Acid SCHEMBL10444676 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL28041983 | 0.94 | SLC34A1 (0.56) | — | |
| Phosphoric Acid SCHEMBL9098971 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL23796792 | 0.94 | SLC34A1 (0.47) | — | |
| Phosphoric Acid SCHEMBL28596999 | 0.91 | SLC34A1 (0.53) | — | |
| Phosphoric Acid SCHEMBL28816396 | 0.90 | SLC34A1 (0.41) | — | |
| Phosphoric Acid SCHEMBL27642790 | 0.90 | SLC34A1 (0.60) | — | |
| Phosphoric Acid SCHEMBL5096806 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000024775-A9 | GENE CLUSTER INVOLVED IN NOGALAMYCIN BIOSYNTHESIS, AND ITS USE IN PRODUCTION OF HYBRID ANTIBIOTICS | GALILAEUS OY (FI) | 2000-08-24 | — | — | WO | disclosed |